Bokus
Jo�o L. de Quevedo, Mario Juruena, Carlos A. Zarate - Neurobiology of Depression, Häftad

Häftad, Engelska, 2027

Neurobiology of Depression

Road to Novel Therapeutics

Av Jo�o L. de Quevedo, Mario Juruena, Carlos A. Zarate

Del i serien Neurobiology of Disease

2767 kr

Kommande

Beskrivning
Neurobiology of Depression: Road to Novel Therapeutics, Second Edition follows the success of the first edition, synthesizing the basic neurobiology of major depressive disorder (MDD) with discussions on the latest research advances, including interacting pathways implicated in the pathophysiology of MDD, omics technologies, genetic approaches, and novel optogenetic techniques revolutionizing depression research. This new edition includes comprehensive foundational understandings of the disorder and highlights recent advances, aiding advanced students and researchers in their understanding of MDD. The book introduces new chapters exploring groundbreaking topics such as the neurobiology of treatment-resistant depression, the antidepressant mechanisms of ketamine, and the link between depression and Alzheimer's disease. Additionally, it covers the neurobiology of suicide in depression, the impact of psychedelics as therapy, and the unique aspects of bipolar depression. This edition also examines computational models in depression, the neurobiology of psychotherapy, and the putative mechanisms of action for vagus nerve stimulation as a therapeutic approach. These additions help to provide a broader and more comprehensive understanding of depression and its treatment.

  • Features new chapters on emerging topics in depression research
  • Explores major depressive disorder (MDD) within the framework of the NIMH Research Domain Criteria (RDoC) recommendations
  • Covers a wide array of existing and potential pharmacologic and non-pharmacologic treatment options
  • Synthesizes discussions on the cellular and molecular mechanisms underlying depressive symptoms with clinical aspects
Produktinformation
  • Utgivningsdatum: 2027-03-01
  • Mått: 216 x 276 x undefined mm
  • Vikt: 450 g
  • Format: Häftad
  • Språk: Engelska
  • Serie: Neurobiology of Disease
  • Antal sidor: 475
  • Upplaga: 2
  • Förlag: Elsevier Science
  • ISBN: 9780443383373
Utforska kategorier
Mer om författaren

João L. de Quevedo, MD, Ph.D., obtained his Medical Degree and completed residency training in Psychiatry, a fellowship in Psychopharmacology, and a Ph.D. in Biological Sciences (Biochemistry), all from the Federal University of Rio Grande do Sul, Porto Alegre, Brazil. He is the John S. Dunn Distinguished Professor at the Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston). He also serves as Professor, Vice-Chair for Faculty Development and Outreach, Executive Director of the Center for Interventional Psychiatry, Chief of the Division of Interventional Psychiatry, Director of the Treatment-Resistant Depression Program, and Program Director of the Interventional Psychiatry Fellowship. Dr. Joao L. de Quevedo is an Associate Editor for Molecular Psychiatry, a Springer Nature journal.Research profiles:ResearcherID: E-5491-2013Scopus Author ID: 56971689500https://orcid.org/0000-0003-3114-6611Mario Juruena, MD, PhD, is Professor of Affective Disorders and Translational Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, within the Centre for Affective Disorders, Department of Psychological Medicine. He is also a Consultant Psychiatrist at South London and Maudsley NHS Foundation Trust (SLaM) and the National Affective Disorders Service. He currently leads the Maudsley Advanced Treatment Service (MATS) for Difficult-to-Treat Depression and Bipolar Disorders and the Maudsley ECT Service.Carlos A. Zarate, MD, is Chief of the Experimental Therapeutics and Pathophysiology Branch at the National Institute of Mental Health. He is a fellow of the American College of Neuropsychopharmacology and member of the Society of Biological Psychiatry and the Society for Neuroscience. Dr. Zarate’s research focuses on the pathophysiology and development of novel therapeutics for treatment-resistant mood disorders as well as the study of biomarkers and neural correlates of treatment response.

Recensioner i media

Select Guide Rating

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.